The agency said it will not take action against pharmacies making copies of Eli Lilly’s blockbuster drug while it reevaluates ...

Eli Lilly shares continue to soar thanks to its new weight loss drugs. With sales of Mounjaro and ZepBound continuing to ...

Learn about GLP-1 medications, their benefits, risks, and who should (or shouldn’t) consider using them. Due to its rise in ...

The FDA said it does not plan to take action against GLP-1 compounders for certain violations while it re-evaluates Eli Lilly ...